Effects of Tuijing Therapy on Heart Rate Variability and Psychological Symptoms
Launched by THE HONG KONG POLYTECHNIC UNIVERSITY · Mar 14, 2025
Trial Information
Current as of April 22, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Procedures The researcher will conduct an initial telephone interview to provide study information and screen potential participants for eligibility. Each participant will receive full details about the study's purpose and will be required to sign an informed consent form. All participants will be invited for two in-person sessions before accepting any intervention. In the first session, comprehensive medical histories, brief semi-structured interviews for psychological symptoms, clinical examinations, general information, and questionnaires will be conducted to determine eligibility. Eligi...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age 18 - 55 years old
- • Willingness to participate in the study and undergo randomization
- • Proficiency in Chinese
- • Absence of severe chronic diseases
- • Experience with depression symptoms for over three months
- • Scoring 20 or higher on the Montreal Cognitive Assessment (MoCA)
- • Scoring above 14 on the Hamilton Depression Rating Scale 17
- Exclusion Criteria:
- • The presence of cardiovascular disease (CVD)
- • Severe head trauma, intracranial hypertension, implanted ferromagnetic devices, or a history of epilepsy
- • Engagement in any pharmacological or non-pharmacological treatments within the past month
- • Existing skin conditions or susceptibility to skin injuries
- • Any form of cognitive impairment
About The Hong Kong Polytechnic University
The Hong Kong Polytechnic University (PolyU) is a leading institution in applied research and education, dedicated to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, PolyU focuses on conducting rigorous and ethically sound research to enhance understanding of medical interventions and improve patient outcomes. The university leverages its multidisciplinary expertise, state-of-the-art facilities, and collaboration with industry partners to facilitate groundbreaking studies that address pressing health challenges. Committed to fostering an environment of academic excellence, PolyU aims to translate research findings into practical solutions that benefit society and contribute to the global advancement of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , Hong Kong
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Related Blog Entries
View all
